NMTC - NeuroOne: Dilution Risk Ahead

2024-02-15 15:30:00 ET

Summary

• NeuroOne is a medical device company developing diagnostic and treatment tools based on thin-film electrode technology.
• The company is targeting a range of neurological disorders, including epilepsy, Parkinson's disease, essential tremors, and dystonia.
• NeuroOne's future is uncertain due to its low market capitalization, limited cash, and ongoing losses.

NeuroOne ( NMTC ) is a medical device company developing diagnostic and treatment tools based on thin-film electrode technology. The company already has electroencephalography recording electrodes and an ablation system cleared by the FDA. The company is also targeting spinal cord and neuro stimulation, and recently began investigating the potential for its devices to guide the delivery of therapeutics into the brain....

For further details see: